Teva Reports Second Quarter 2012 Results MarketWatch (press release) "The U.S. generics business continued to recover with a positive trend, our global branded division experienced strong growth, and our European generics business, while down from last year's second quarter results due to macroeconomic conditions ...
No comments:
Post a Comment